NCT06295614View on ClinicalTrials.gov

Study on Preliminary Safety and Efficacy of the ARC-IM Therapy to Alleviate Locomotor Deficits in People With Parkinson's Disease

NARecruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 14, 2024

Primary Completion Date

April 1, 2029

Study Completion Date

April 1, 2029

Conditions
Parkinson Disease
Interventions
DEVICE

ARC-IM System implantation

Implantation of a stimulation lead on the lumbar level of the spinal cord and implantation of a neurostimulator in the abdominal region.

Trial Locations (1)

1011

RECRUITING

Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne

All Listed Sponsors
lead

Ecole Polytechnique Fédérale de Lausanne

OTHER